Vulnerability in Becton Dickinson & Co Bd Bactec™ Blood Culture System

CVE-2024-10476

Default credentials are used in the above listed BD Diagnostic Solutions products. If exploited, threat actors may be able to access, modify or delete data, including sensitive information such as protected health information (PHI) and personally identifiable information (PII). Exploitation of this vulnerability may allow an attacker to shut down or otherwise impact the availability of the system. Note: BD Synapsys™ Informatics Solution is only in scope of this vulnerability when installed on a NUC server. BD Synapsys™ Informatics Solution installed on a customer-provided virtual machine or on the BD Kiestra™ SCU hardware is not in scope.

EPSS: 0.002 (14.9th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 8.0 (High). Vector: CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2024-10476?
CVE-2024-10476 is a high-severity vulnerability in Becton Dickinson & Co Bd Bactec™ Blood Culture System, classified under CWE-1392. CVSS score: 8.0/10. Published 2024-12-17.
How severe is CVE-2024-10476?
High severity. CVSS v3 base score is 8.0 out of 10.